ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 89 filers reported holding ALLOVIR INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,005 | -75.7% | 34,421 | -55.9% | 0.00% | -100.0% |
| Q2 2022 | $304,000 | -61.1% | 78,029 | -32.6% | 0.00% | -50.0% |
| Q1 2022 | $782,000 | -31.7% | 115,818 | +30.9% | 0.00% | 0.0% |
| Q4 2021 | $1,145,000 | +38.5% | 88,450 | +168.1% | 0.00% | 0.0% |
| Q3 2021 | $827,000 | +8.5% | 32,997 | -14.6% | 0.00% | 0.0% |
| Q2 2021 | $762,000 | -9.1% | 38,623 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $838,000 | – | 35,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |